Explore more publications!

Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on February 13, 2026

Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science
Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway
Patient Champion for Intermountain Health Primary Children’s Hospital to Receive National Recognition and Be Featured on Cereal Boxes Nationwide
Ocular Therapeutix™ to Announce Topline Data for SOL-1 Phase 3 Superiority Trial in Wet AMD on Tuesday, February 17, 2026
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement
Inotiv Provides Notice Regarding Cybersecurity Incident
Longeveron® Appoints Stephen H. Willard as Chief Executive Officer
Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results
Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
Edesa Biotech Reports Fiscal 1st Quarter 2026 Results
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4DMT Announces New Employment Inducement Grants
SRX Health Solutions Inc. Announces Fiscal First Quarter 2026 Results for Quarter Ended December 31, 2025
Paretofit Launches Digital Health Coaching System for Entrepreneurs in Europe’s DACH Region
Dr. Ian Weisberg Grant for Future Healthcare Leaders Announces National Scholarship Supporting the Next Generation of Medical Professionals
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Romeo Orthopaedics Hosts Successful Open House Event
Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents
Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
Valneva fait un point sur l’utilisation du vaccin IXCHIQ®  au Royaume-Uni

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions